Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Imatinib mesylate in patients with C-Kit expressing adenoid cystic cancer of the salivary glands: a Princess Margaret Hospital phase II consortium study

Hotte SJ, Winquist EW, Lamont EB, MacKenzie M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A, Siu LL. Imatinib mesylate in patients with C-Kit expressing adenoid cystic cancer of the salivary glands: a Princess Margaret Hospital phase II consortium study. Journal of Clinical Oncology. 2005; 23 :585-590.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.